BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago Branicks Group AG Reports Operationally Successful Financial Year for 2023 Despite Market Challenges Real Estate Sustainability Market Conditions Branicks Group AG Financial Results 2023
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago Branicks Group AG annonce un exercice financier 2023 réussi sur le plan opérationnel malgré les défis du marché Immobilier Résultats Financiers 2023 Durabilité Branicks Group SA Les Conditions Du Marché
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago FUCHS SE Reports Mixed Results in Q1 2024 Despite Challenges Financial Outlook 2024 FUCHS SE EBIT Growth Quarterly Financials LUBCON Acquisition
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago FUCHS SE annonce des résultats mitigés au premier trimestre 2024 malgré les défis FUCHS SE Croissance De L'EBIT Rapports Financiers Trimestriels Acquisition De LUBCON Perspectives Financières 2024
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago DocMorris AG Completes CHF 200 Million Convertible Bonds Offering Investor Relations Convertible Bonds Financial Strategy CHF 200 Million DocMorris AG
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago DocMorris AG finalise une émission d'obligations convertibles de 200 millions de CHF Stratégie Financière Liens Convertibles Relations Avec Les Investisseurs DocMorris AG 200 Millions De Francs
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago ALSO Holding Announces New CEO, Wolfgang Krainz Operational Efficiency Corporate Leadership Executive Appointment ICT Industry Company Growth Strategies
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago ALSO Holding annonce la nomination d'un nouveau PDG, Wolfgang Krainz Efficacité Opérationnelle Nomination À La Direction Industrie Des TIC Direction D'entreprise Stratégies De Croissance De L'entreprise
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago Newron Reports Success in Evenamide Schizophrenia Study Evenamide Schizophrenia Treatment Treatment-resistant Phase II/III Study Glutamatergic Inhibition
BRIEF published on 04/30/2024 at 07:05, 6 months 20 days ago Newron annonce le succès de son étude sur la schizophrénie Evenamide Evenamide Résistant Aux Traitements Traitement De La Schizophrénie Étude De Phase II/III Inhibition Glutamatergique
Published on 11/20/2024 at 10:00, 35 minutes ago PostSig Raises $1.2 Million in Pre-Seed Funding Led by Frontier Venture Capital, With Participation From SaaS Ventures and Prominent Industry Leaders
Published on 11/20/2024 at 01:20, 9 hours 15 minutes ago Athena Bitcoin Reports Third Quarter 2024 Financial Results
Published on 11/20/2024 at 00:15, 10 hours 20 minutes ago Caldwell Reports Fourth Quarter and Full Year Results and Declares Quarterly Dividend
Published on 11/20/2024 at 10:18, 17 minutes ago Nuways and Quirin Privatbank publish new research reports on the new beaconsmind and Swissnet Group – Webcast on November 20 and participation in the Deutsches Eigenkapitalforum
Published on 11/20/2024 at 09:16, 1 hour 19 minutes ago Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy
Published on 11/20/2024 at 09:00, 1 hour 35 minutes ago Announcement on the payment of the cash distribution of the capital reduction of STRABAG SE resolved on 16 June 2023 to the holders of value rights
Published on 11/20/2024 at 07:45, 2 hours 50 minutes ago Gimv veräußert Mehrheitsbeteiligung am ambulanten Rehabilitationsspezialisten rehaneo an Fremman Capital
Published on 11/20/2024 at 07:45, 2 hours 50 minutes ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
Published on 11/20/2024 at 07:45, 2 hours 50 minutes ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
Published on 11/20/2024 at 07:45, 2 hours 50 minutes ago Gimv verkoopt meerderheidsbelang in rehaneo, Duitse specialist in ambulante revalidatie, aan Fremman Capital
Published on 11/20/2024 at 07:00, 3 hours 35 minutes ago ACTIA GROUP : CHIFFRE D'AFFAIRES DU 3EME TRIMESTRE 2024
